131 related articles for article (PubMed ID: 20446863)
1. Evolving pharmacotherapeutic strategies for small bowel adenocarcinoma.
Trikudanathan G; Dasanu CA
Expert Opin Pharmacother; 2010 Jul; 11(10):1695-704. PubMed ID: 20446863
[TBL] [Abstract][Full Text] [Related]
2. Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study.
Zaanan A; Gauthier M; Malka D; Locher C; Gornet JM; Thirot-Bidault A; Tougeron D; Taïeb J; Bonnetain F; Aparicio T;
Cancer; 2011 Apr; 117(7):1422-8. PubMed ID: 21425142
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma.
Overman MJ; Kopetz S; Wen S; Hoff PM; Fogelman D; Morris J; Abbruzzese JL; Ajani JA; Wolff RA
Cancer; 2008 Oct; 113(8):2038-45. PubMed ID: 18759326
[TBL] [Abstract][Full Text] [Related]
4. Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectives.
Zaaimi Y; Aparicio T; Laurent-Puig P; Taieb J; Zaanan A
Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):154-60. PubMed ID: 26547136
[TBL] [Abstract][Full Text] [Related]
5. The evolving management of small bowel adenocarcinoma.
de Bree E; Rovers KP; Stamatiou D; Souglakos J; Michelakis D; de Hingh IH
Acta Oncol; 2018 Jun; 57(6):712-722. PubMed ID: 29381126
[TBL] [Abstract][Full Text] [Related]
6. A Single Institutional Analysis of Systemic Therapy for Unresectable or Recurrent Small Bowel Adenocarcinoma.
Makino S; Takahashi H; Haraguchi N; Nishimura J; Hata T; Matsuda C; Ikenaga M; Murata K; Yamamoto H; Doki Y; Mori M; Mizushima T
Anticancer Res; 2017 Mar; 37(3):1495-1500. PubMed ID: 28314324
[TBL] [Abstract][Full Text] [Related]
7. Management of small bowel adenocarcinoma.
Kummar S; Ciesielski TE; Fogarasi MC
Oncology (Williston Park); 2002 Oct; 16(10):1364-9; discussion 1370, 1372-3. PubMed ID: 12435206
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review.
Nishikawa Y; Hoshino N; Horimatsu T; Funakoshi T; Hida K; Sakai Y; Muto M; Nakayama T
Int J Clin Oncol; 2020 Aug; 25(8):1441-1449. PubMed ID: 32448950
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy in advanced small bowel adenocarcinoma.
Locher C; Malka D; Boige V; Lebray P; Elias D; Lasser P; Ducreux M
Oncology; 2005; 69(4):290-4. PubMed ID: 16282708
[TBL] [Abstract][Full Text] [Related]
10. Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Arain MA; Chen YJ; Ciombor KK; Cohen SA; Cooper HS; Deming DA; Garrido-Laguna I; Grem JL; Hoffe SE; Hubbard J; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen KS; Saltz LB; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Johnson-Chilla A; Gregory KM; Gurski LA
J Natl Compr Canc Netw; 2019 Sep; 17(9):1109-1133. PubMed ID: 31487687
[TBL] [Abstract][Full Text] [Related]
11. Acute myelogenous leukemia following irinotecan-based chemotherapy for adenocarcinoma of the small intestine.
Patel S; Liu D; Caron P; Seiter K
Leuk Lymphoma; 2007 May; 48(5):1032-3. PubMed ID: 17487750
[No Abstract] [Full Text] [Related]
12. Management of small bowel adenocarcinoma: making the most of the available evidence to inform routine practice.
Mazlom H; Teuwen LA; Peeters M
Curr Opin Oncol; 2021 Jul; 33(4):368-371. PubMed ID: 33882527
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency.
Czaykowski P; Hui D
Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):143-9. PubMed ID: 17355111
[TBL] [Abstract][Full Text] [Related]
14. Irinotecan as salvage chemotherapy for advanced small bowel adenocarcinoma: a series of three patients.
Polyzos A; Kouraklis G; Giannopoulos A; Bramis J; Delladetsima JK; Sfikakis PP
J Chemother; 2003 Oct; 15(5):503-6. PubMed ID: 14598944
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.
Overman MJ; Varadhachary GR; Kopetz S; Adinin R; Lin E; Morris JS; Eng C; Abbruzzese JL; Wolff RA
J Clin Oncol; 2009 Jun; 27(16):2598-603. PubMed ID: 19164203
[TBL] [Abstract][Full Text] [Related]
16. Small bowel adenocarcinoma as a complication of celiac disease: clinical and diagnostic features.
Caio G; Volta U; Ursini F; Manfredini R; De Giorgio R
BMC Gastroenterol; 2019 Mar; 19(1):45. PubMed ID: 30917787
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of Body Mass Index in Advanced Small Bowel Adenocarcinoma Patients Receiving Palliative Chemotherapy.
Lee DW; Lee KH; Kim TY; Han SW; Oh DY; Im SA; Kim TY; Bang YJ
Nutr Cancer; 2016 Jul; 68(5):750-5. PubMed ID: 27282771
[TBL] [Abstract][Full Text] [Related]
18. What are the latest pharmacotherapy options for small bowel adenocarcinoma?
Ynson ML; Senatore F; Dasanu CA
Expert Opin Pharmacother; 2014 Apr; 15(6):745-8. PubMed ID: 24588646
[TBL] [Abstract][Full Text] [Related]
19. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases.
Fishman PN; Pond GR; Moore MJ; Oza A; Burkes RL; Siu LL; Feld R; Gallinger S; Greig P; Knox JJ
Am J Clin Oncol; 2006 Jun; 29(3):225-31. PubMed ID: 16755174
[TBL] [Abstract][Full Text] [Related]
20. Small intestinal adenocarcinoma: rarely considered, often missed?
Neely D; Ong J; Patterson J; Kirkpatrick D; Skelly R
Postgrad Med J; 2013 Apr; 89(1050):197-201. PubMed ID: 23412393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
